Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS)
暂无分享,去创建一个
D. Roccatello | S. Sciascia | A. Tincani | A. Fioravanti | L. Andreoli | C. Nalli | A. Alunno | G. Emmi | F. Conti | C. Alessandri | F. Carubbi | I. Cecchi | A. Hoxha | A. Calligaro | B. Raffeiner | M. Larosa | M. Gerosa | F. Franceschini | G. Sebastiani | M. Urban | G. Pazzola | M. Radin | M. Lazzaroni | S. Truglia | V. Ramoni | F. Fischetti | V. Canti | A. Barinotti | E. Rubini | S. Foddai | Cecillia B. Chighizola
[1] M. Gatto,et al. Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion. , 2020, Rheumatology.
[2] D. Roccatello,et al. Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome , 2020, Thrombosis and Haemostasis.
[3] P. Sfikakis,et al. The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study. , 2020, Autoimmunity reviews.
[4] V. Pengo,et al. Tetra positive thrombotic antiphospholipid syndrome: Major contribution of anti‐phosphatidyl‐serine/prothrombin antibodies to lupus anticoagulant activity , 2020, Journal of thrombosis and haemostasis : JTH.
[5] Liyan Wan,et al. Anti-β2GPI domain 1 antibodies stratify high risk of thrombosis and late pregnancy morbidity in a large cohort of Chinese patients with antiphospholipid syndrome. , 2019, Thrombosis research.
[6] E. Samoli,et al. Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus , 2019, Annals of the rheumatic diseases.
[7] R. Wong,et al. A review of 10 years of data from an external quality assurance program for antiphospholipid antibodies: no evidence for improved aCL and β2GPI assay standardization , 2019 .
[8] D. Roccatello,et al. Prevalence of Antiphospholipid Antibodies Negativisation in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Multicentre Study , 2019, Thrombosis and Haemostasis.
[9] A. Tincani,et al. Autoantibodies’ titre modulation by anti-BlyS treatment in systemic lupus erythematosus , 2019, Lupus.
[10] M. Ward,et al. EULAR recommendations for the management of antiphospholipid syndrome in adults , 2019, Annals of the rheumatic diseases.
[11] E. Silvestri,et al. Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment. , 2019, Autoimmunity reviews.
[12] D. Roccatello,et al. Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab , 2018, Annals of the rheumatic diseases.
[13] S. Sciascia,et al. Can we withdraw anticoagulation in patients with antiphospholipid syndrome after seroconvertion? , 2017, Autoimmunity reviews.
[14] D. Roccatello,et al. Prevalence and Thrombotic Risk Assessment of Anti-β2 Glycoprotein I Domain I Antibodies: A Systematic Review , 2017, Seminars in Thrombosis and Hemostasis.
[15] D. Roccatello,et al. HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies , 2017, Seminars in Thrombosis and Hemostasis.
[16] L. Jara,et al. Antiphospholipid antibodies disappearance in primary antiphospholipid syndrome: Thrombosis recurrence. , 2017, Autoimmunity reviews.
[17] O. Decaux,et al. Cessation of oral anticoagulants in antiphospholipid syndrome , 2017, Lupus.
[18] Chrong-Reen Wang,et al. Rituximab usage in systemic lupus erythematosus-associated antiphospholipid syndrome: A single-center experience. , 2016, Seminars in arthritis and rheumatism.
[19] D. Roccatello,et al. The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies , 2015, Thrombosis and Haemostasis.
[20] M. Galli. Treatment of the antiphospholipid syndrome , 2013, Autoimmunity Highlights.
[21] D. Roccatello,et al. GAPSS: the Global Anti-Phospholipid Syndrome Score. , 2013, Rheumatology.
[22] G. Espinosa,et al. Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative , 2013, Immunologic research.
[23] D. Roccatello,et al. Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities , 2012, Journal of thrombosis and haemostasis : JTH.
[24] Takao Koike,et al. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. , 2012, Arthritis and rheumatism.
[25] D. Roccatello,et al. Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome , 2011, Lupus.
[26] P. Meroni,et al. Pathogenesis of antiphospholipid syndrome: understanding the antibodies , 2011, Nature Reviews Rheumatology.
[27] J. Douketis,et al. Evidence and clinical judgment: Treatment of cerebral vein thrombosis , 2010, Thrombosis and Haemostasis.
[28] S. Iliceto,et al. Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome , 2010, Journal of thrombosis and haemostasis : JTH.
[29] Á. Blanco-Molina,et al. Retirada de la anticoagulación en el síndrome antifosfolípido primario cuando se negativizan los anticuerpos anticardiolipina , 2008 .
[30] Y. Shoenfeld,et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.
[31] E. Harris,et al. The antiphospholipid syndrome , 1995, Clinical reviews in allergy & immunology.